These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 516224)

  • 1. Long term use of intravenous insulin because of failure of subcutaneous insulin treatment.
    Diaz-Pereda L; Yang TI; Knowles HC
    Trans Am Clin Climatol Assoc; 1979; 90():102-8. PubMed ID: 516224
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of 2 therapeutic regimens using fractionated doses of insulin in insulin-dependent diabetics].
    Hajri S; Ben Slama CL; Chamakhi S; Bessioud M; Mebazaa R; Boukhris R
    Tunis Med; 1985 Nov; 63(11):589-93. PubMed ID: 3835734
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-acting basal insulin].
    Meißner T
    MMW Fortschr Med; 2015 Jul; 157(13):82. PubMed ID: 26206056
    [No Abstract]   [Full Text] [Related]  

  • 5. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New flexibility in diabetes therapy].
    Danne T
    MMW Fortschr Med; 2015 Feb; 157(3):65. PubMed ID: 25743681
    [No Abstract]   [Full Text] [Related]  

  • 7. [New freedoms in insulin therapy].
    MMW Fortschr Med; 2015 Feb; 157(3):64. PubMed ID: 25743674
    [No Abstract]   [Full Text] [Related]  

  • 8. Ultralente and multiple shots of regular insulin.
    Sindler B; Mersey JH
    Md Med J; 1992 Dec; 41(12):1131. PubMed ID: 1291838
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between subcutaneous blood flow and absorption of lente type insulin.
    Hildebrant P; Mehlsen J; Birch K; Kühl C
    Diabetes Res; 1987 Apr; 4(4):179-81. PubMed ID: 3621801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative evaluation of the effectiveness of insulin preparations "Lente GP" and "Insulong" in type 1 diabetes mellitus].
    Kudriakova SV; Belovanova IM; Romanovskaia GA; Kasymov UA
    Sov Med; 1991; (9):75-7. PubMed ID: 1798933
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes.
    Porcellati F; Rossetti P; Ricci NB; Pampanelli S; Torlone E; Campos SH; Andreoli AM; Bolli GB; Fanelli CG
    Diabetes Care; 2007 May; 30(5):1261-3. PubMed ID: 17303785
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intensified insulin therapy: single dose substitution of meal unrelated (basal) need for insulin by long-acting human zinc insulin].
    Spuck W; Schweinebraten A; Thun C; Gerdes H
    Med Klin (Munich); 1987 Jan; 82(2):51-5. PubMed ID: 3550404
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of ultralente insulin in cats with diabetes mellitus.
    Nelson RW; Feldman EC; DeVries SE
    J Am Vet Med Assoc; 1992 Jun; 200(12):1828-9. PubMed ID: 1639685
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-acting insulin analog, glargine, in the treatment of type 1 diabetes].
    Tuomi T
    Duodecim; 2004; 120(1):88-92. PubMed ID: 14976814
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term use of intramuscular insulin therapy in a type I diabetic patient with subcutaneous insulin resistance.
    Brossard JH; Havrankova J; Rioux D; Bertrand S; D'Amour P
    Diabet Med; 1993 Mar; 10(2):174-6. PubMed ID: 8458196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous insulin resistance syndrome. Effects of long-term aprotinin therapy.
    Guillausseau PJ; Guillausseau C; Boucheteil P; Lubetzki J
    Diabetes Res; 1986 Sep; 3(7):387-9. PubMed ID: 2430751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin detemir: new drug. A second long-acting insulin analogue: many uncertainties, few advantages.
    Prescrire Int; 2006 Oct; 15(85):163-7. PubMed ID: 17121210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conventional insulin treatment and treatment using multiple injections in diabetes mellitus].
    Hildebrandt R; Madsbad S
    Ugeskr Laeger; 1989 Jul; 151(31):1960-7. PubMed ID: 2672490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selecting an insulin program for type 1 diabetes.
    Scheiner G
    Diabetes Self Manag; 2003; 20(5):54-6, 58. PubMed ID: 14679953
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of injection techniques for soluble and protamine zinc insulins in diabetes mellitus.
    Harrower AD; Duncan LJ; Clarke BF
    Practitioner; 1975 Feb; 214(1280):228-31. PubMed ID: 1144249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.